Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Pramipexole Treatment in Resistant Obsessive-Compulsive Disorder (OCD): Pilot, Randomized and Controlled Clinical Trial

NCT06611592 is registered in ClinicalTrials.gov with Clinical Academic Center (2CA-Braga) as lead sponsor.

NCT NCT06611592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06611592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Pramipexole Treatment in Resistant Obsessive-Compulsive Disorder (OCD): Pilot, Randomized and Controlled Clinical Trial
Lead sponsor
Clinical Academic Center (2CA-Braga)
Phase
Phase 2
Overall status
Recruiting
Start date
August 20, 2024
Completion date
August 20, 2028
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obsessive-compulsive disorder